Weight-Loss Drugs Remain Off Wada Banned List for 2027

The World Anti-Doping Agency (WADA) has announced that weight-loss drugs will not be included on its Prohibited List for 2027. This decision means that athletes will not face bans for using these substances under the current anti-doping regulations. However, WADA will maintain these drugs on its monitoring program for the upcoming year. The monitoring program allows WADA to gather more information on the prevalence and patterns of use of certain substances within sports, without imposing immediate sanctions.

This decision follows extensive deliberations and consideration of scientific evidence and expert opinions. WADA's Executive Committee reviewed recommendations from its List Expert Group and the Health and Medical Education Committee. The agency has been closely observing the increasing popularity and availability of weight-loss medications, particularly those that affect metabolic pathways or appetite. The concern is that some of these substances could potentially enhance athletic performance, either directly or indirectly, by aiding in weight management or improving body composition.

While not banned, the continued monitoring signifies WADA's ongoing vigilance. The agency aims to ensure a level playing field in sports and protect the health of athletes. By keeping these drugs under observation, WADA can assess whether they pose a significant risk of abuse or performance enhancement in the future. This approach allows for a more informed decision-making process regarding future list inclusions. The monitoring data will be crucial in determining whether these substances warrant a place on the Prohibited List in subsequent years.

Athletes and their support personnel are advised to remain aware of WADA's monitoring program and the evolving landscape of prohibited substances. While current regulations permit the use of these weight-loss drugs, the situation could change. WADA's Prohibited List is updated annually, with the 2027 list set to be published by September 30, 2026. The agency encourages athletes to consult the WADA Code and seek guidance from their respective National Anti-Doping Organizations (NADOs) if they have any questions regarding specific medications or substances. The focus remains on maintaining the integrity of sport and safeguarding athlete well-being through robust anti-doping measures.